Thrombin-activatable fibrinolysis inhibitor and activated factor XII in patients with systemic lupus erythematosus.
Ringwald
Juergen
J
Buettner
Stefanie
S
Zimmermann
Robert
R
Weisbach
Volker
V
Strasser
Erwin
E
Eckstein
Reinhold
R
Eckel
Karin
K
Manger
Karin
K
D000293:Adolescent; D000328:Adult; D000368:Aged; D025901:Carboxypeptidase B2 / Q000627:therapeutic use*; D016022:Case-Control Studies; D015331:Cohort Studies; D015956:Factor XIIa / Q000627:therapeutic use*; D005260:Female; D006487:Hemostasis; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D013923:Thromboembolism / Q000097:blood / Q000517:prevention & control*
D025901:Carboxypeptidase B2; D015956:Factor XIIa